News

Eric Laney - Master's Thesis Defense

March 28, 2018

Use of the Montreal Cognitive Assessment as an Early Indicator of Tumor Progression in Patients with Stage III and IV Gliomas

Wednesday, April 4, 2018
12:00 p.m.
Spectrum Health, Conference Rm. 3001
25 Michigan St.

Committee members:
Prof. Deb Burg, BMS (chair); Dr. Wendy Sherman, Spectrum Health Neuro-oncology,  Dr. Steven Pastyrnak, Helen DeVos Children’s Hospital

Share this news story

View More News



Page last modified March 28, 2018